← Back to Search


Curcumin for Tinnitus

Waitlist Available
Led By Seilish Babu, MD
Research Sponsored by Ascension South East Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults with subjective tinnitus due to sensorineural hearing loss as determined by routine audiogram.
Adults with subjective tinnitus due to sensorineural hearing loss as determined by routine audiogram.
Screening 3 weeks
Treatment Varies
Follow Up evaluate at the beginning of the trial and at the end of the 30 day treatment period.
Awards & highlights

Study Summary

This trial will study whether highly bioavailable curcumin can help to reduce tinnitus symptoms.

Who is the study for?
This trial is for adults who have ringing in their ears (tinnitus) because of hearing loss from nerve damage. They must not be allergic to the test compounds, pregnant, using other tinnitus treatments like certain medications or counseling, or taking blood thinners.Check my eligibility
What is being tested?
The study is testing if a form of curcumin that's easy for the body to use can help with tinnitus. Participants will either get this special curcumin or a placebo and answer surveys about their tinnitus before and after treatment.See study design
What are the potential side effects?
Curcumin might cause digestive upset, headaches, rashes, or yellow stool. It could also interact with other drugs. However, since it's generally considered safe at low doses, serious side effects are rare.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I have tinnitus due to hearing loss, confirmed by a hearing test.
I have ringing in my ears due to nerve-related hearing loss.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~evaluate at the beginning of the trial and at the end of the 30 day treatment period.
This trial's timeline: 3 weeks for screening, Varies for treatment, and evaluate at the beginning of the trial and at the end of the 30 day treatment period. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean change on the Tinnitus Functional Index (TFI)
Secondary outcome measures
Determine Changes in the Tinnitus Handicap Inventory (THI)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Treatment GroupExperimental Treatment1 Intervention
Subjects will be provided with a supply of capsules containing 500 mg of curcumin-phosphatidylcholine combined with 250 mg of boswellia-phosphatidyl. Subjects will take 1 capsule by mouth twice daily for 30 days.
Group II: Placebo GroupPlacebo Group1 Intervention
Subjects will be provided with a placebo compound with instructions to take 1 capsule by mouth twice daily for 30 days.

Find a Location

Who is running the clinical trial?

Ascension South East MichiganLead Sponsor
18 Previous Clinical Trials
33,080 Total Patients Enrolled
Seilish Babu, MDPrincipal InvestigatorMichigan Ear Institute
1 Previous Clinical Trials
6 Total Patients Enrolled

Media Library

Highly Bioavailable Curcumin (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04800107 — N/A
Tinnitus Research Study Groups: Treatment Group, Placebo Group
Tinnitus Clinical Trial 2023: Highly Bioavailable Curcumin Highlights & Side Effects. Trial Name: NCT04800107 — N/A
Highly Bioavailable Curcumin (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04800107 — N/A
Tinnitus Patient Testimony for trial: Trial Name: NCT04800107 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you provide details of past experiments utilizing Curcumin-phosphatidylcholine?

"Currently, 5 trials with Curcumin-phosphatidylcholine are in the latter stages of development and 21 experiments remain active. Despite most trials being hosted in Hamilton, Ontario, there are 30 sites running these studies altogether."

Answered by AI

What is the enrollment size of this medical experiment?

"Affirmative. According to the data hosted on clinicaltrials.gov, this research is actively recruiting patients, which began when it was initially posted in June 2021 and most recently updated in March 2022. 110 participants need to be recruited from 3 distinct locations."

Answered by AI

Would individuals over the age of 30 be accepted as participants in this research?

"The trial is open to individuals between 18 and 99 years of age."

Answered by AI

Is enrollment for this study still open?

"Affirmative, current details of the trial available on clinicaltrials.gov depict that recruitment is in progress. This project was established on June 1st 2021 and edited lastly on March 21st 2022; 110 individuals are desired to take part across 3 medical centres."

Answered by AI

Who meets the criteria to participate in this research project?

"To take part in this trial, participants must report subjective tinnitus and be between 18-99 years old. The research team is looking to recruit 110 individuals altogether."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
< 18
18 - 65
What site did they apply to?
Michigan Ear Institute
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?

Why did patients apply to this trial?

TINITUS IS A BURDEN. I would love help for Tinnitus. I’m motivated to help find something that will.
PatientReceived 2+ prior treatments
Hoping to stop the ringing in my ears for years. I am increasingly hearing louder ringing and some aches.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

What is the time commitment?
PatientReceived 2+ prior treatments
Recent research and studies
~41 spots leftby Dec 2025